विवरण

Co-prescribing two SSRIs leads to additive serotonin excess with no therapeutic benefit and high risk of serotonin syndrome.

तंत्र

Both escitalopram and sertraline inhibit the serotonin transporter (SERT); concurrent use causes additive blockade and serotonin accumulation.

नैदानिक महत्व

Combination offers no evidence-based advantage and increases serotonin toxicity risk significantly.

प्रबंधन

Contraindicated; switch fully from one SSRI to another with appropriate washout period rather than combining.

चिकित्सा अस्वीकरण

This content is for educational and informational purposes only. It is not a substitute for professional medical advice, diagnosis, or treatment. Always consult a qualified healthcare provider before making medication decisions.

Data sources: ChEMBL, PubChem, DailyMed.